Surgical resection combined with chop chemotherapy plus rituximab for a patient with advanced mesenteric diffuse large B cell lymphoma

Hepato-Gastroenterology

Volumn 55, Issue 84, 2008, Pages 891-894

  Yamaguchi, Tetsuya ^a   Takahashi, Hiroshi ^a   Kagawa, Ryuzaburou ^a   Takeda, Ryoji ^a   Sakata, Shingo ^a   Nishizaki, Daisuke ^a   Takamatsu, Teruyuki ^a   Iwasa, Yoko ^a  

^a RAKUWAKAI OTOWA HOSPITAL   (Japan)

Author keywords

Diffuse large B cell lymphoma; Mesenterium; Rituximab; Surgical resection

Indexed keywords

CD20 ANTIBODY; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; INTERLEUKIN 2 RECEPTOR; LACTATE DEHYDROGENASE; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ABDOMINAL TUMOR; ADVANCED CANCER; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DUODENUM BIOPSY; ECHOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; LARGE CELL LYMPHOMA; MALE; MESENTERY LYMPH NODE; MESOCOLON; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARALYTIC ILEUS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGMOID; SWELLING; TUMOR VOLUME;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLON, SIGMOID; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; HUMANS; ILEUM; LYMPH NODES; LYMPHOMA, LARGE B-CELL, DIFFUSE; MAGNETIC RESONANCE IMAGING; MALE; MESENTERY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PREDNISOLONE; TOMOGRAPHY, X-RAY COMPUTED; VINCRISTINE;

EID: 47149108294     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Mentzer SJ, Osteen RT, Pappas TN, Rosenthal DS, Canellos GP, Wilson RE: Surgical therapy of localized abdominal non-Hodgkin's lymphomas. Surgery 1988; 103:609-614.
2. Jones SE, Fuks Z, Bull M, Kadin ME, Dorfman RF, Kaplan HS, Rosenberg SA, Kim H: Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer 1973; 31:806-823.
3. Jagannath S, Velasquez WS, Tucker SL, Fuller LM, McLaughlin PW, Manning JT, North LB, Cabanillas FC: Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma. J Clin Oncol 1986; 4:859-865.
4. Romaguera JE, Velasquez WS, Silvermintz KB, Fuller LB, Hagemeister FB, McLaughlin P, Cabanillas F: Surgical debulking is associated with improved survival in Stage I-II diffuse large cell lymphoma. Cancer 1990; 66:267-272.
5. Romaguera JE, Velasquez WS, Silvermintz KB, Fuller LB, Hagemeister FB, McLaughlin P, Swan F, Redman JR, Rodriguez MA, Cabanillas F: Stage I and II diffuse large cell lymphoma: prognostic factors and long-term results with CHOP-Bleo and radiotherapy. Blood 1991; 77:942-947.
6. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, van den Neste E, Salles G, Gaulard P, Reyes F, Gisselbrecht C: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346:235-242.
7. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M: Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31:1860-1861.
8. Noronha V, Shafi NQ, Obando JA, Kummar S: Primary non-Hodgkin's lymphoma of the liver. Crit Rev Oncol Hematol 2005; 53:199-207.
9. The non-Hodgkin's lymphoma pathologic classification project: National-Cancer-Institute sponsored study of classification of non Hodgkin's lymphomas: summary and description of a Working Formulation for clinical usage. Cancer 1982; 49:2112-2135.
10. Harris NL, Jaffe ES, Stern N, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Herm link HK, Pileri SA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-1392.
11. Fisher RI: Clinical behavior of 2168 patients trend on Southwest Oncology Group (SWOG) protocols and classified according to the R.E.A.L. classification. Ann Oncol 1996; 7:3.
12. Harris NL: Principles of lymphoma classification, Proceeding of the Clinical Implications of the Revised European-American Lymphoma Classification, March 4-6. Boston, 1996.
13. Santos ES, Raez LE, Salvatierra J, Morgensztern D, Shanmugan N, Neff G: Primary hepatic non-Hodgkin's lymphomas: case report and review of the literature. Am J Gastroenterol 2003; 98:2789-2793.
14. Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, Rabb R, Newman RA, Hanna N, Anderson DR: Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD 20. Blood 1994; 83:435-445.
15. Coiffier B, Haioun C, Ketterer N, Engert A, Tilly H, Ma D, Johnson P, Lister A, Feuring-Buske M, Radford JA, Capdeville R, Diehl V, Reyes F: Rituximab (anti-CD 20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood 1998; 92:1927-1932.